To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis
Status:
Recruiting
Trial end date:
2024-11-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind phase II clinical study to evaluate the efficacy and
safety of AK111 in the treatment of subjects with moderate to severe plaque psoriasis.